Becker muscular dystrophy (BMD) is a type of muscular dystrophy, a genetic condition that weakens and damages muscles. It can worsen with age. However, its symptoms are less severe than those of ...

A new article argues dystrophin immunogenicity is an under-examined issue in the treatment of Duchenne muscular dystrophy.

Discover growth opportunities with Edgewise Therapeutics, Inc. in the hypertrophic cardiomyopathy market. Click for my EWTX ...

DMD was first described by French neurologist Guillaume Benjamin Amand Duchenne in the 1860s. However, until the 1980s, ...

Multiparametric qMRI effectively differentiates between DMD and BMD in ambulatory children ... help differentiate between Duchenne muscular dystrophy and Becker muscular dystrophy early and ...

Three other diseases that fall into this group are: Becker muscular dystrophy or Becker Muscular Dystrophy (BMD), this is a mild form of DMD Intermediate clinical presentation between DMD and BMD ...

The company currently focuses on EDG-5506 as its primary drug candidate because it aims to stop skeletal muscle damage in patients with DMD and BMD ... both Becker and Duchenne muscular dystrophy ...

Researchers from Edgewise Therapeutics Inc. have previously developed and characterized a novel bmx mouse model of Becker muscular dystrophy (BMD), which harbors a deletion of murine Dystrophin exons ...